In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat version of Bayer's patented anti-cancer drug, Nexavar, bringing down its price by 97%. In the first-ever case of compulsory licencing approval, the Indian Patent Office on Monday cleared the application of Hyderabad's Natco Pharma to sell generic drug Nexavar,...
More »SEARCH RESULT
Total Matching Records found : 1345
Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »India's patent ruling on cancer may open door for cheaper HIV drugs
-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »Economic growth and food security depend on healthy farm sector, whose pillar, the farmer, is still neglected by Ajay S Shriram
In India, agriculture and allied sector is the source of income for over 60% of rural population and its contribution to GDP has been consistently coming down and currently stands at 14.3%. For the Indian economy to grow at the rate of 8-9%, the growth rate of agriculture sector has to be more than 4%. The critical role of agriculture in the economy highlights the need for a larger investment in...
More »A scam in pulses import? CAG estimates Rs 1,200 crore loss on import of subsidised pulses by Tejinder Narang
In December 2011, CAG tabled a well-analysed audit report in Parliament claiming a loss of 1,200 crore, or $250 million, on the import of subsidised pulses through 2006-11 under the supervision of department of consumer affairs (DCA) of the food ministry. The government's intention to introduce such a scheme cannot be faulted: during 2005-08, seven million tonnes of wheat was imported at high prices, chana (chickpeas) values spiked from 21...
More »
